MD4877C1 - Pharmaceutical composition and solid oral delayed release tablet of S-adenosylmethionine - Google Patents

Pharmaceutical composition and solid oral delayed release tablet of S-adenosylmethionine

Info

Publication number
MD4877C1
MD4877C1 MDA20220032A MD20220032A MD4877C1 MD 4877 C1 MD4877 C1 MD 4877C1 MD A20220032 A MDA20220032 A MD A20220032A MD 20220032 A MD20220032 A MD 20220032A MD 4877 C1 MD4877 C1 MD 4877C1
Authority
MD
Moldova
Prior art keywords
adenosylmethionine
delayed release
solid oral
release tablet
pharmaceutical composition
Prior art date
Application number
MDA20220032A
Other languages
Romanian (ro)
Russian (ru)
Other versions
MD4877B1 (en
MD20220032A2 (en
Inventor
Санджив ГУПТА
Раджив ГУПТА
Тг ЧАНДРАШЕКХАР
Свати МУКХЕРДЖИ
Амит ГУПТА
Original Assignee
Kusum Healthcare Private Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kusum Healthcare Private Limited filed Critical Kusum Healthcare Private Limited
Publication of MD20220032A2 publication Critical patent/MD20220032A2/en
Publication of MD4877B1 publication Critical patent/MD4877B1/en
Publication of MD4877C1 publication Critical patent/MD4877C1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

The present invention relates to a composition and a solid oral delayed release tablet of S-adenosylmethionine or its pharmaceutically acceptable salt, an enteric coat layer of copolymer of methacrylic acid and a secondary layer in appropriate amounts.
MDA20220032A 2019-11-25 2020-01-28 Pharmaceutical composition and solid oral delayed release tablet of S-adenosylmethionine MD4877C1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN201911048100 2019-11-25
PCT/IN2020/050091 WO2021106004A1 (en) 2019-11-25 2020-01-28 Pharmaceutical composition of s-adenosylmethionine

Publications (3)

Publication Number Publication Date
MD20220032A2 MD20220032A2 (en) 2022-10-31
MD4877B1 MD4877B1 (en) 2023-12-31
MD4877C1 true MD4877C1 (en) 2024-07-31

Family

ID=76130121

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20220032A MD4877C1 (en) 2019-11-25 2020-01-28 Pharmaceutical composition and solid oral delayed release tablet of S-adenosylmethionine

Country Status (3)

Country Link
MD (1) MD4877C1 (en)
MX (1) MX2022005714A (en)
WO (1) WO2021106004A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114306266A (en) * 2022-01-06 2022-04-12 济南同路医药科技发展有限公司 Enteric composition of adenosine methionine butanedisulfonate and preparation method thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6759395B2 (en) * 2000-12-18 2004-07-06 Orchid Chemicals & Pharmaceuticals, Ltd. Soft-gelatin capsule comprising S-adenosylmethionine and a method for producing the same
FR2823211A1 (en) * 2001-04-10 2002-10-11 Virbac Sa New compositions containing an S-adenosyl-L-methionine polyphosphate, useful as anti-inflammatories, antidepressants and in treatment of osteoarthritis comprises improved stability and greater activity than free S-adenosyl-L-methionine
US20110027342A1 (en) * 2009-07-28 2011-02-03 Msi Methylation Sciences, Inc. S-adenosylmethionine formulations with enhanced bioavailability

Also Published As

Publication number Publication date
MX2022005714A (en) 2022-06-08
MD4877B1 (en) 2023-12-31
WO2021106004A1 (en) 2021-06-03
MD20220032A2 (en) 2022-10-31

Similar Documents

Publication Publication Date Title
CL2017003320A1 (en) Pharmaceutical formulations containing tenofovir and emtricitabine
CO6531485A2 (en) SOLID PHARMACEUTICAL COMPOSITIONS CONTAINING AN INTEGRESS INHIBITOR
MX2021016109A (en) Methods and compositions particularly for treatment of attention deficit disorder.
JP2013508289A5 (en)
HRP20240701T1 (en) Compositions for use in the treatment of hypertension
MX2018000084A (en) Pharmaceutical composition containing amlodipine, valsartan, and rosuvastatin.
EP3616685A4 (en) Method for determining authenticity of pharmaceutical composition for oral administration, pharmaceutical composition for oral administration, and system for determining authenticity of pharmaceutical composition for oral administration
IL280083A (en) Pharmaceutical dosage form which can be administered orally and has modified release
PH12016500693B1 (en) Slow-release solid oral compositions
TR201721505A2 (en) The combination comprising linagliptin and metformin
MD4877B1 (en) Pharmaceutical composition and solid oral delayed release tablet of S-adenosylmethionine
MX2024009106A (en) Pharmaceutical composition containing acetominophen and ibuprofen.
WO2016091805A3 (en) Naloxone monopreparation and multi-layer tablet
EA201991286A1 (en) A SOLID PHARMACEUTICAL COMPOSITION FOR ORAL USE CONTAINING TENOFOVIR AND EMTRITSITABIN
WO2017064652A3 (en) Low dose oral dipyridamole compositions and uses thereof
CO2018002046A2 (en) New oral delayed dual dexlansoprazole oral composition
SA517380942B1 (en) Plurimodal Release Formulation of Doxylamine and Pyridoxine and/or Metabolites or Salts Thereof
TW201613584A (en) Plurimodal release formulation of doxylamine and pyridoxine and/or metabolites or salts thereof
EP4052699A4 (en) Orally administered solid dosage form drug
TR201722039A2 (en) SOLID ORAL PHARMACEUTICAL COMPOSITIONS OF MESALAZINE
EA201991007A1 (en) SOLID PHARMACEUTICAL COMPOSITIONS BASED ON LURAZIDONE HYDROCHLORIDE FOR ORAL USE
MX2021016044A (en) Dichlorphenamide compositions and methods of use.
WO2016187595A3 (en) Oral pharmaceutical composition of methylergonovine
MX2017014725A (en) Dropropizine in combination with ambroxol in the dosage form of syrup or tablets.
MX2021004553A (en) Pharmaceutical compositions and methods of making on demand solid dosage formulations.

Legal Events

Date Code Title Description
FG4A Patent for invention issued